{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:49Z","timestamp":1786988149638,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejps.2019.105202","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T12:43:11Z","timestamp":1576759391000},"page":"105202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Optimal oral anticoagulant therapy in Chinese patients with mechanical heart valves"],"prefix":"10.1016","volume":"144","author":[{"given":"Heng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-6510","authenticated-orcid":false,"given":"Li","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.105202_bib0001","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.94.9.2107","article-title":"AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves","volume":"94","author":"Acar","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2019.105202_bib0002","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jtcvs.2007.12.002","article-title":"Guidelines for reporting mortality and morbidity after cardiac valve interventions","volume":"135","author":"Akins","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejps.2019.105202_bib0003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-5223(19)40105-0","article-title":"Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves","volume":"72","author":"Altman","year":"1976","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejps.2019.105202_bib0004","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","article-title":"The pharmacology and management of the vitamin K antagonists. The seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Ansell","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ejps.2019.105202_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2019.105202_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","article-title":"Optimal oral anticoagulant therapy in patients with mechanical heart valves","volume":"333","author":"Cannegieter","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2019.105202_bib0007","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/0003-4975(89)90089-1","article-title":"Hematological complications with the St. Jude valve and reduced-dose Coumadin","volume":"48","author":"DiSesa","year":"1989","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ejps.2019.105202_bib0008","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0735-1097(99)00598-7","article-title":"Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study","volume":"35","author":"Laffort","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejps.2019.105202_bib0009","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11239-011-0574-9","article-title":"Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician","volume":"31","author":"Leiria","year":"2011","journal-title":"J. Thromb. Thrombol."},{"key":"10.1016\/j.ejps.2019.105202_bib0010","first-page":"83","article-title":"Anticoagulant therapy after prosthetic valve replacement-optimal PT-INR in Japanese patients","volume":"8","author":"Mori","year":"2002","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejps.2019.105202_bib0011","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology\/american heart association task force on practice guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejps.2019.105202_bib0012","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1076029607302544","volume":"13","author":"Pengo","year":"2007","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.ejps.2019.105202_bib0013","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jtcvs.2014.01.004","article-title":"Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized food and drug administration investigational device exemption trial","volume":"147","author":"Puskas","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejps.2019.105202_bib0014","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejps.2019.105202_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","article-title":"Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends","volume":"374","author":"Sun","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2019.105202_bib0016","first-page":"1175","article-title":"Low standard oral anticoagulation therapy for Chinese patients with St. Jude mechanical heart valves","volume":"116","author":"Sun","year":"2003","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ejps.2019.105202_bib0017","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ahj.2010.05.005","article-title":"LOWERing the INtensity of oral anticoaGulant therapy in patients with bileaflet mechanical aortic valve replacement: results from the \"LOWERING-IT\" trial","volume":"160","author":"Torella","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejps.2019.105202_bib0018","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archinternmed.2009.176","article-title":"Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients","volume":"169","author":"Torn","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejps.2019.105202_bib0019","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2019.105202_bib0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/PL00007265","article-title":"Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: a preliminary report from a single institution using conversion from thrombotest to PT-INR","volume":"15","author":"Uetsuka","year":"2000","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ejps.2019.105202_bib0021","doi-asserted-by":"crossref","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ejps.2019.105202_bib0022","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1378\/chest.100.6.1553","article-title":"Low-intensity anticoagulation in mechanical cardiac prosthetic valves","volume":"100","author":"Wilson","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.ejps.2019.105202_bib0023","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2125.2005.02361.x","article-title":"Is INR between 2.0 and 3.0 the optimal level for chinese patients on warfarin therapy for moderate-intensity anticoagulation?","volume":"59","author":"You","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105202_bib0024","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/021849230501300410","article-title":"Low-Dose anticoagulation in Chinese patients with mechanical heart valves","volume":"13","author":"Zhou","year":"2005","journal-title":"Asian Cardiovasc. Thorac. Ann."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719304750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719304750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:49:31Z","timestamp":1760528971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719304750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":24,"alternative-id":["S0928098719304750"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105202","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal oral anticoagulant therapy in Chinese patients with mechanical heart valves","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105202"}}